Kapstone Financial Advisors’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
Sell
-3,995
Closed -$236K 109
2024
Q2
$236K Sell
3,995
-1,327
-25% -$83K 0.15% 88
2024
Q1
$424K Hold
5,322
0.29% 64
2023
Q4
$383K Sell
5,322
-336
-6% -$23.9K 0.3% 65
2023
Q3
$395K Sell
5,658
-233
-4% -$16.5K 0.36% 56
2023
Q2
$436K Sell
5,891
-235
-4% -$16.7K 0.36% 57
2023
Q1
$462K Buy
6,126
+2,663
+77% +$223K 0.42% 54
2022
Q4
$298K Buy
+3,463
New +$334K 0.27% 73

Other funds holding CVS

Kapstone Financial Advisors's CVS Position: Q3 2024 in Review

Kapstone Financial Advisors sold out of CVS Health (CVS) in Q3 2024, closing a stake of 3,995 shares — an estimated $236K sold.

Kapstone Financial Advisors first reported a position in CVS in Q4 2022 and held it in 7 quarters. The position peaked at $462K in Q1 2023. 1,840 funds tracked by Wall St. Rank hold CVS as of Q3 2024.

  • Kapstone Financial Advisors reported no remaining CVS Health position as of Q3 2024 after selling out during the quarter.
  • Kapstone Financial Advisors sold 3,995 CVS Health shares in Q3 2024, an estimated $236K.
  • Kapstone Financial Advisors first reported a position in CVS Health in Q4 2022 and held it in 7 quarters.
  • Kapstone Financial Advisors's CVS Health position peaked at $462K in Q1 2023.
  • 1,840 funds tracked by Wall St. Rank held CVS Health as of Q3 2024.

Based on Kapstone Financial Advisors's 13F filing for Q3 2024, filed 6 Nov 2024.